Cargando…

Psychosocial factors partially explain gender differences in health‐related quality of life in heart failure patients

AIMS: There is little information about the influence of gender on quality of life (QoL) in heart failure. The purpose of this study was to evaluate whether the health‐related QoL gap between men and women can be explained by the interaction between psychosocial factors and clinical determinants in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tapia, Javier, Basalo, María, Enjuanes, Cristina, Calero, Esther, José, Nuria, Ruíz, Marta, Calvo, Elena, Garcimartín, Paloma, Moliner, Pedro, Hidalgo, Encarna, Yun, Sergi, Garay, Alberto, Jiménez‐Marrero, Santiago, Pons, Alexandra, Corbella, Xavier, Colet, Josep Comín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053343/ https://www.ncbi.nlm.nih.gov/pubmed/36582154 http://dx.doi.org/10.1002/ehf2.14260

Ejemplares similares

Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure
por: Alcoberro, Lidia, et al.
Publicado: (2023)

Use of potassium-binder patiromer for up-titration of renin–angiotensin–aldosterone system inhibition therapy in a patient with chronic heart failure and reduced ejection fraction followed in a multidisciplinary integrated chronic care management programme: a case report
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study
por: Rubio, Raül, et al.
Publicado: (2021)

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?
por: Moliner, Pedro, et al.
Publicado: (2019)

Usefulness of telemedicine-based heart failure monitoring according to “eHealth literacy” domains: insights from the iCOR randomised controlled trial
por: Yun Viladomat, S, et al.
Publicado: (2022)

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study
por: Garay, Alberto, et al.
Publicado: (2020)

Transcultural adaptation and validation of the patient empowerment in long-term conditions questionnaire
por: Garcimartin, Paloma, et al.
Publicado: (2017)

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
por: Yun, Sergi, et al.
Publicado: (2020)

Validation of the Spanish version of the questionnaire on Patient Empowerment in Long-Term Conditions
por: Garcimartín, Paloma, et al.
Publicado: (2020)

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
por: Ras-Jiménez, Maria del Mar, et al.
Publicado: (2023)

Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
por: Alcaide-Aldeano, Alex, et al.
Publicado: (2020)

Adaptación transcultural al español del cuestionario Patient empowerment in long-term conditions
por: Garcimartin, Paloma, et al.
Publicado: (2019)

Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
por: Farré, Núria, et al.
Publicado: (2017)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
por: González-Costello, José, et al.
Publicado: (2018)

Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
por: Díez-López, Carles, et al.
Publicado: (2021)

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells
por: Tajes, M., et al.
Publicado: (2021)

Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
por: Carrera, Mª José, et al.
Publicado: (2021)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction
por: Cristóbal, Helena, et al.
Publicado: (2023)

Bloqueo auriculoventricular de tercer grado asociado a la vacuna de ARNm contra el SARS-CoV-2
por: Pons-Riverola, Alexandra, et al.
Publicado: (2023)

Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine
por: Pons-Riverola, Alexandra, et al.
Publicado: (2023)

Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
por: Sindone, Andrew, et al.
Publicado: (2022)

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Response
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

The Psychosocial Benefits of Sport Participation During COVID-19 Are Only Partially Explained by Increased Physical Activity
por: Watson, Andrew M., et al.
Publicado: (2022)

Patient risk factors for developing a drug-related problem in a cardiology ward
por: Urbina, Olatz, et al.
Publicado: (2014)

Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients
por: González-Moneo, María J, et al.
Publicado: (2016)

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs
por: Garcia-Elias, Anna, et al.
Publicado: (2017)

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey
por: Howlett, Jonathan, et al.
Publicado: (2017)

Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
por: Oyanguren, Juana, et al.
Publicado: (2017)

Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review
por: Comín-Colet, Josep, et al.
Publicado: (2020)

Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
por: Macdougall, Iain C., et al.
Publicado: (2020)

Atrial Fibrillation in Heart Failure Is Associated with High Levels of Circulating microRNA-199a-5p and 22–5p and a Defective Regulation of Intracellular Calcium and Cell-to-Cell Communication
por: Garcia-Elias, Anna, et al.
Publicado: (2021)

Ecological Model Explaining the Psychosocial Adaptation to COVID-19
por: Gaspar, Tânia, et al.
Publicado: (2022)

13th Traffic and Granular Flow Conference
por: Zuriguel, Iker, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6suhs0eukeodstvtlrj63h5sgk